| BMPE |
Bone Marrow Pathology Evaluation |
Anatomic Pathology |
| BMPE |
Bone Marrow Pathology Evaluation |
Anatomic Pathology |
| CYTO BM |
Chromosome Analysis Bone Marrow |
Cytogenetics |
| CYTO LN |
Chromosome Analysis Lymph Node (Lymphoma) |
Cytogenetics |
| CYTO LPB |
Chromosome Analysis Leukemic Peripheral Blood (Oncology) |
Cytogenetics |
| F 4Q12 |
FIP1L1/PDGFRA 4q12 Rearrangement |
FISH |
| F AML Frontline |
Acute Myeloid Leukemia (AML) Frontline Panel |
FISH |
| F AML Secondary |
Acute Myeloid Leukemia (AML) Secondary Panel |
FISH |
| F AML::ETO |
AML::ETO; t(8;21) |
FISH |
| F BCL3 |
BCL3 19q13 Rearrangement |
FISH |
| F BCL6 |
BCL6 3q27 Rearrangement |
FISH |
| F BCR::ABL1 |
BCR::ABL1; t(9;22) |
FISH |
| F BURKITT |
Burkitt/"Double Hit" Large B-cell Lymphoma Panel |
FISH |
| F CBFB |
CBFB::MYH11; t(16;16) / inv(16) |
FISH |
| F CLL |
Chronic Lymphocytic Leukemia (CLL) Panel |
FISH |
| F CLL Vysis |
Vysis Chronic Lymphocytic Leukemia (CLL) Panel |
FISH |
| F CMYC |
C MYC 8q24 Rearrangement |
FISH |
| F DEK::NUP214 |
DEK::NUP214; t(6;9) |
FISH |
| F EOS |
Eosinophilia FISH Panel |
FISH |
| F ETV6::RUNX1 |
ETV6::RUNX1; t(12;21) |
FISH |
| F FGFR1 |
FGFR1 8p11.2 Rearrangement |
FISH |
| F IGH |
IGH 14q32 Rearrangement |
FISH |
| F IGH::BCL2 |
IGH::BCL2; t(14;18) |
FISH |
| F IGH::BCL2 |
IGH::BCL2; t(14;18) |
FISH |
| F IGH::BCL2 |
IGH::BCL2; t(14;18) |
FISH |
| F IGH::CCND1 |
IGH::CCND1 (BCL1); t(11;14) |
FISH |
| F IGH::CCND1 |
IGH::CCND1 (BCL1); t(11;14) |
FISH |
| F IGH::FGFR3 |
IGH::FGFR3; t(4;14) |
FISH |
| F IGH::MAF |
IGH::MAF; t(14;16) |
FISH |
| F IGH::MALT1 |
IGH::MALT1; t(14;18) |
FISH |
| F IGH::MYC |
IGH::MYC; t(8;14) |
FISH |
| F IRF4 |
IRF4 6p25 Rearrangement |
FISH |
| F MALT1 |
MALT1 18q21 Rearrangement |
FISH |
| F MDS |
Myelodysplasia (MDS) Panel |
FISH |
| F MECOM |
MECOM 3q26 Rearrangement |
FISH |
| F MLL |
MLL(KMT2A) 11q23 Gene Rearrangement |
FISH |
| F MM |
Plasma Cell Neoplasms Panel |
FISH |
| F MMREF |
MM Reflex Panel – IGH/FGFR3 and IGH/MAF |
FISH |
| F MPD |
Myeloproliferative Disorders (MPD) Panel |
FISH |
| F NUP98 |
NUP98 11p15 Rearrangement |
FISH |
| F PDGFRB |
PDGFRB 5q32 Rearrangement |
FISH |
| F PRDM16 |
PRDM16 1p36 Rearrangement |
FISH |
| F URO |
Bladder Cancer Panel +3,+7,+17,9p21- |
FISH |
| FP ALK |
ALK 2p23 Rearrangement, paraffin |
FISH |
| FP BCL6 |
BCL6 3q27 Rearrangement, paraffin |
FISH |
| FP BURKITT |
Burkitt/"Double Hit" Large B-cell Lymphoma Panel, paraffin |
FISH |
| FP CMYC |
C MYC 8q24 Rearrangement, paraffin |
FISH |
| FP HER2 |
HER2/neu Breast Cancer, paraffin |
FISH |
| FP HER2 GA |
HER2/neu Gastric Cancer, paraffin |
FISH |
| FP IGH |
IGH 14q32 Rearrangement, paraffin |
FISH |
| FP IGH |
IGH 14q32 Rearrangement, paraffin |
FISH |
| FP IGH::BCL2 |
IGH::BCL2; t(14;18), paraffin |
FISH |
| FP IGH::CCND1 |
IGH::CCND1 (BCL1); t(11;14), paraffin |
FISH |
| FP IGH::CCND1 |
IGH::CCND1 (BCL1); t(11;14), paraffin |
FISH |
| FP IGH::MYC |
IGH::MYC; t(8;14), paraffin |
FISH |
| FP IRF4 |
IRF4 6p25 Rearrangement, paraffin |
FISH |
| FP ROS1 |
ROS1 6q22.1 Rearrangement, paraffin |
FISH |
| FLOW |
Leukemia/Non-Hodgkin Lymphoma |
Flow Cytometry |
| FLOW BAL |
Bronchoalveolar Lavage |
Flow Cytometry |
| FLOW CD4* |
T-cell Subsets, CD4:CD8 Ratio and Count |
Flow Cytometry |
| FLOW M |
Combined Flow Cytometry and Morphology Review |
Flow Cytometry |
| FLOW PNH |
Paroxysmal Nocturnal Hemoglobinuria (PNH) by FLAER (High Sensitivity) |
Flow Cytometry |
| FLOW TC |
Flow Cytometry, technical only |
Flow Cytometry |
| I ER |
Estrogen Receptor |
IHC |
| I ER TC |
Estrogen Receptor, technical only |
IHC |
| I ERA |
Epithelial-Related antigen (MOC-31) |
IHC |
| I ERA TC |
Epithelial-Related antigen (MOC-31), technical only |
IHC |
| I HER2 |
HER2 neu |
IHC |
| I HER2 GA |
Her2/neu Gastric cancer |
IHC |
| I HER2 GA TC |
Her2/neu Gastric cancer, technical only |
IHC |
| I HER2 TC |
HER2 neu, technical only |
IHC |
| I KI67 |
Ki67 |
IHC |
| I KI67 TC |
Ki67, technical only |
IHC |
| I P53 |
P53 |
IHC |
| I P53 TC |
P53, technical only |
IHC |
| I PD-L1 (SP263) |
PD-L1 (SP263) |
IHC |
| I PR |
Progesterone Receptor |
IHC |
| I PR TC |
Progesterone Receptor, technical only |
IHC |
| I PRAME |
PRAME |
IHC |
| I PRAME RED |
PRAME red |
IHC |
| I PRAME RED TC |
PRAME red, technical only |
IHC |
| I PRAME TC |
PRAME, technical only |
IHC |
| I PROEXC TC* |
ProExC™ Biomarker, technical only |
IHC |
| I PROEXC* |
ProExC™ Biomarker |
IHC |
| M BCELL |
B-cell lg Heavy Chain Gene Rearrangement |
Molecular |
| M BCR ABL |
BCR/ABL1 qRT PCR |
Molecular |
| M BCR ABL COMBINED |
BCR/ABL1 qRT PCR, major and minor |
Molecular |
| M BCR ABLm |
BCR/ABL1 qRT PCR, minor |
Molecular |
| M BRAF |
BRAF V600 Mutation Analysis |
Molecular |
| M FLT3 |
FLT3 Mutation Analysis |
Molecular |
| M IgVH |
IgVH Mutational Status |
Molecular |
| M JAK2 |
JAK2 V617F Mutation Analysis |
Molecular |
| M KIT P* |
KIT D816V Mutation, paraffin |
Molecular |
| M MYD88 |
MYD88 L265P Mutation Analysis |
Molecular |
| M NGS HEME |
Myeloid Malignancy NGS Panel |
Molecular |
| M Solid Tumor NGS |
Solid Tumor NGS Panel (22 genes) |
Molecular |
| M TCR |
T-cell Receptor Gamma Gene Rearrangement |
Molecular |
| M TP53 |
TP53 Mutation Analysis |
Molecular |